Clinical dividends from the molecular genetic diagnosis of craniosynostosis.

A dozen years have passed since the first genetic lesion was identified in a family with craniosynostosis, the premature fusion of the cranial sutures. Subsequently, mutations in the FGFR2, FGFR3, TWIST1, and EFNB1 genes have been shown to account for approximately 25% of craniosynostosis, whilst se...

Full description

Bibliographic Details
Main Authors: Wilkie, A, Bochukova, E, Hansen, R, Taylor, I, Rannan-Eliya, S, Byren, J, Wall, SA, Ramos, L, Venâncio, M, Hurst, J, O'rourke, A, Williams, L, Seller, A, Lester, T
Format: Journal article
Language:English
Published: 2007
_version_ 1797078919751401472
author Wilkie, A
Bochukova, E
Hansen, R
Taylor, I
Rannan-Eliya, S
Byren, J
Wall, SA
Ramos, L
Venâncio, M
Hurst, J
O'rourke, A
Williams, L
Seller, A
Lester, T
author_facet Wilkie, A
Bochukova, E
Hansen, R
Taylor, I
Rannan-Eliya, S
Byren, J
Wall, SA
Ramos, L
Venâncio, M
Hurst, J
O'rourke, A
Williams, L
Seller, A
Lester, T
author_sort Wilkie, A
collection OXFORD
description A dozen years have passed since the first genetic lesion was identified in a family with craniosynostosis, the premature fusion of the cranial sutures. Subsequently, mutations in the FGFR2, FGFR3, TWIST1, and EFNB1 genes have been shown to account for approximately 25% of craniosynostosis, whilst several additional genes make minor contributions. Using specific examples, we show how these discoveries have enabled refinement of information on diagnosis, recurrence risk, prognosis for mental development, and surgical planning. However, phenotypic variability can present a significant challenge to the clinical interpretation of molecular genetic tests. In particular, the difficulty of analyzing the complex interaction of genetic background and prenatal environment in determining clinical features, limits the value of identifying low penetrance mutations. (c) 2007 Wiley-Liss, Inc.
first_indexed 2024-03-07T00:38:24Z
format Journal article
id oxford-uuid:8233d9b3-2a34-4dc0-97d8-2457468610c8
institution University of Oxford
language English
last_indexed 2024-03-07T00:38:24Z
publishDate 2007
record_format dspace
spelling oxford-uuid:8233d9b3-2a34-4dc0-97d8-2457468610c82022-03-26T21:35:45ZClinical dividends from the molecular genetic diagnosis of craniosynostosis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:8233d9b3-2a34-4dc0-97d8-2457468610c8EnglishSymplectic Elements at Oxford2007Wilkie, ABochukova, EHansen, RTaylor, IRannan-Eliya, SByren, JWall, SARamos, LVenâncio, MHurst, JO'rourke, AWilliams, LSeller, ALester, TA dozen years have passed since the first genetic lesion was identified in a family with craniosynostosis, the premature fusion of the cranial sutures. Subsequently, mutations in the FGFR2, FGFR3, TWIST1, and EFNB1 genes have been shown to account for approximately 25% of craniosynostosis, whilst several additional genes make minor contributions. Using specific examples, we show how these discoveries have enabled refinement of information on diagnosis, recurrence risk, prognosis for mental development, and surgical planning. However, phenotypic variability can present a significant challenge to the clinical interpretation of molecular genetic tests. In particular, the difficulty of analyzing the complex interaction of genetic background and prenatal environment in determining clinical features, limits the value of identifying low penetrance mutations. (c) 2007 Wiley-Liss, Inc.
spellingShingle Wilkie, A
Bochukova, E
Hansen, R
Taylor, I
Rannan-Eliya, S
Byren, J
Wall, SA
Ramos, L
Venâncio, M
Hurst, J
O'rourke, A
Williams, L
Seller, A
Lester, T
Clinical dividends from the molecular genetic diagnosis of craniosynostosis.
title Clinical dividends from the molecular genetic diagnosis of craniosynostosis.
title_full Clinical dividends from the molecular genetic diagnosis of craniosynostosis.
title_fullStr Clinical dividends from the molecular genetic diagnosis of craniosynostosis.
title_full_unstemmed Clinical dividends from the molecular genetic diagnosis of craniosynostosis.
title_short Clinical dividends from the molecular genetic diagnosis of craniosynostosis.
title_sort clinical dividends from the molecular genetic diagnosis of craniosynostosis
work_keys_str_mv AT wilkiea clinicaldividendsfromthemoleculargeneticdiagnosisofcraniosynostosis
AT bochukovae clinicaldividendsfromthemoleculargeneticdiagnosisofcraniosynostosis
AT hansenr clinicaldividendsfromthemoleculargeneticdiagnosisofcraniosynostosis
AT taylori clinicaldividendsfromthemoleculargeneticdiagnosisofcraniosynostosis
AT rannaneliyas clinicaldividendsfromthemoleculargeneticdiagnosisofcraniosynostosis
AT byrenj clinicaldividendsfromthemoleculargeneticdiagnosisofcraniosynostosis
AT wallsa clinicaldividendsfromthemoleculargeneticdiagnosisofcraniosynostosis
AT ramosl clinicaldividendsfromthemoleculargeneticdiagnosisofcraniosynostosis
AT venanciom clinicaldividendsfromthemoleculargeneticdiagnosisofcraniosynostosis
AT hurstj clinicaldividendsfromthemoleculargeneticdiagnosisofcraniosynostosis
AT orourkea clinicaldividendsfromthemoleculargeneticdiagnosisofcraniosynostosis
AT williamsl clinicaldividendsfromthemoleculargeneticdiagnosisofcraniosynostosis
AT sellera clinicaldividendsfromthemoleculargeneticdiagnosisofcraniosynostosis
AT lestert clinicaldividendsfromthemoleculargeneticdiagnosisofcraniosynostosis